Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.
PMID | Journal | Published Date | Author | Title |
---|---|---|---|---|
11250901 | EMBO J. | 2001 | Muth V et al. | Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. |
11714976 | J. Gen. Virol. | 2001 | Hatama S et al. | Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera. |
11991990 | J. Virol. | 2002 | Gradoville L et al. | Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. |
12692061 | Gut | 2003 | Schauber J et al. | Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. |
14557628 | J. Virol. | 2003 | Lu F et al. | Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. |
15308471 | Am. J. Physiol. Gastrointest. Liver Physiol. | 2004 | Gaudier E et al. | Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. |
15269190 | Drug Metab. Dispos. | 2004 | Sanderson L et al. | Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice. |
19805354 | Proc. Natl. Acad. Sci. U.S.A. | 2009 | Gibbs A et al. | Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. |
17371805 | J. Pharmacol. Exp. Ther. | 2007 | Kim HJ et al. | Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. |
17626110 | Eur. Respir. J. | 2007 | Dombrowsky H and Uhlig S | Steroids and histone deacetylase in ventilation-induced gene transcription. |
17431121 | Mol. Cancer Ther. | 2007 | De los Santos M et al. | Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. |
18310117 | J. Exp. Biol. | 2008 | Jiang Y et al. | Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. |
15557281 | J. Biol. Chem. | 2005 | Varshochi R et al. | ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. |
16234266 | Am. J. Physiol. Endocrinol. Metab. | 2006 | Sato TA and Mitchell MD | Molecular inhibition of histone deacetylation results in major enhancement of the production of IL-1beta in response to LPS. |
15930180 | J. Endocrinol. | 2005 | Gunin AG et al. | Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. |
16513842 | Mol. Cancer Res. | 2006 | Rokhlin OW et al. | Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. |
18451057 | Microbiology (Reading, Engl.) | 2008 | van West P et al. | Internuclear gene silencing in Phytophthora infestans is established through chromatin remodelling. |
22955928 | Blood | 2012 | Sadoul K et al. | HDAC6 controls the kinetics of platelet activation. |
22693257 | J. Lipid Res. | 2012 | Nunes MJ et al. | Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway. |